{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:29:21Z","timestamp":1753892961088,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Prenatal drug use may cause toxicity to bone health in newborns. We aimed to examine whether birth outcomes mediate the association between medication use and neonatal metabolic bone disease (MBD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective cohort of 10,801 pregnant women (17\u201349\u2009years) and their infants followed at a single center from 1 January 2012 to 31 December 2021 were included. Based on four single drugs, comprehensive medication use was determined and categorized into three groups using latent-class analysis: group 1 included antibiotics and furosemide or less than two drugs except for MgSO<jats:sub>4<\/jats:sub>; group 2 included MgSO<jats:sub>4<\/jats:sub> without antibiotics or furosemide; and group 3 encompassed dexamethasone and antibiotics. Mediation analysis was conducted to assess the mediating effects of prematurity, low birth weight (LBW), and small for gestational age (SGA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 138 (1.3%) infants with MBD; 2,701 (25%) were born preterm, 1717 (15.9%) had LBW, and 303 (2.8%) were SGA. Pregnant women in groups 2 and 3 were 2.52 to 14.66 times more likely to deliver an infant with MBD than those in group 1. Only LBW showed a significant mediating effect on the association between comprehensive medication use and MBD, with a mediation proportion of 51.8% (45.0\u201364.1%, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Comprehensive medication use during pregnancy was associated with an increased risk of neonatal MBD, largely mediated by LBW. Early antepartum monitoring and prevention targeting adverse birth outcomes are necessary to mitigate the risk of MBD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1377070","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:30:06Z","timestamp":1727670606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Do birth outcomes mediate the association between drug use in pregnancy and neonatal metabolic bone disease? A prospective cohort study of 10,801 Chinese women"],"prefix":"10.3389","volume":"12","author":[{"given":"Honglin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Canavese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huajing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jcte.2014.06.004","article-title":"Metabolic bone disease of prematurity","volume":"1","author":"Rustico","year":"2014","journal-title":"J Clin Transl Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e12861","DOI":"10.1097\/MD.0000000000012861","article-title":"Risk factors analysis and prevention of metabolic bone disease of prematurity","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/jpc.13813","article-title":"Outcomes of standardised approach to metabolic bone disease of prematurity","volume":"54","author":"Chin","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"F560","DOI":"10.1136\/archdischild-2018-316330","article-title":"Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences","volume":"104","author":"Chinoy","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0269180","DOI":"10.1371\/journal.pone.0269180","article-title":"Risk factors for metabolic bone disease of prematurity: a Meta-analysis","volume":"17","author":"Wang","year":"2022","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.siny.2019.101069","article-title":"History, epidemiology and prevalence of neonatal bone mineral metabolic disorders","volume":"25","author":"Schulz","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fped.2019.00143","article-title":"Metabolic bone disease of prematurity: diagnosis and management","volume":"7","author":"Faienza","year":"2019","journal-title":"Front Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1002988","DOI":"10.1371\/journal.pmed.1002988","article-title":"Antenatal magnesium Sulphate and adverse neonatal outcomes: a systematic review and Meta-analysis","volume":"16","author":"Shepherd","year":"2019","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1004183","DOI":"10.1371\/journal.pmed.1004183","article-title":"Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: a Nationwide cohort study","volume":"20","author":"Choi","year":"2023","journal-title":"PLoS Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40264-016-0479-9","article-title":"The risk of adverse pregnancy outcome after first trimester exposure to H1 antihistamines: a systematic review and Meta-analysis","volume":"40","author":"Etwel","year":"2017","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e28310","DOI":"10.1097\/MD.0000000000028310","article-title":"Association between the prolonged use of magnesium sulfate for Tocolysis and fracture risk among infants","volume":"100","author":"Wen","year":"2021","journal-title":"Medicine"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.apsb.2022.05.029","article-title":"Developmental toxicity and programming alterations of multiple organs in offspring induced by medication during pregnancy","volume":"13","author":"Lu","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/cid\/civ437","article-title":"Lower newborn bone mineral content associated with maternal use of Tenofovir Disoproxil fumarate during pregnancy","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"733823","DOI":"10.3389\/fped.2021.733823","article-title":"Maternal-fetal pharmacology of drugs: a review of current status of the application of physiologically based pharmacokinetic models","volume":"9","author":"Chaphekar","year":"2021","journal-title":"Front Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1053\/beog.2001.0231","article-title":"Drugs in pregnancy. Pharmacokinetics in pregnancy","volume":"15","author":"Dawes","year":"2001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3109\/14767058.2015.1025743","article-title":"Evaluation of bone metabolism in newborn twins using quantitative ultrasound and biochemical parameters","volume":"29","author":"Kara","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1055\/s-0041-1729559","article-title":"Risk factors and clinical characteristics of metabolic bone disease of prematurity","volume":"40","author":"Mutlu","year":"2023","journal-title":"Am J Perinatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.earlhumdev.2017.06.010","article-title":"Risk factors of metabolic bone disease of prematurity","volume":"112","author":"Ukarapong","year":"2017","journal-title":"Early Hum Dev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e2251849","DOI":"10.1001\/jamanetworkopen.2022.51849","article-title":"Artificial neural network modeling to predict neonatal metabolic bone disease in the prenatal and postnatal periods","volume":"6","author":"Jiang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3934\/publichealth.2016.2.348","article-title":"Risks and benefits of magnesium sulfate Tocolysis in preterm labor (Ptl)","volume":"3","author":"Elliott","year":"2016","journal-title":"AIMS Public Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"CD000025","DOI":"10.1002\/14651858.CD000025.pub2","article-title":"Magnesium Sulphate and other anticonvulsants for women with pre-eclampsia","volume":"2010","author":"Duley","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3109\/14767058.2013.852180","article-title":"Management of Chronic Hypertension during Pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial","volume":"27","author":"Vigil-De Gracia","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/0002-9378(69)90121-5","article-title":"Advantages and disadvantages of furosemide in the edematous states of pregnancy","volume":"105","author":"Finnerty","year":"1969","journal-title":"Am J Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"CD004454","DOI":"10.1002\/14651858.CD004454.pub4","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"12","author":"McGoldrick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/phar.1649","article-title":"A review of antibiotic use in pregnancy","volume":"35","author":"Bookstaver","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i10","article-title":"Polca: an R package for Polytomous variable latent class analysis","volume":"42","author":"Linzer","year":"2011","journal-title":"J Stat Softw"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0095798420930932","article-title":"Latent class analysis: a guide to best practice","volume":"46","author":"Weller","year":"2020","journal-title":"J Black Psychol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/ppe.12733","article-title":"Drug-drug interactions in pregnancy: an important frontier for Pharmacoepidemiology","volume":"35","author":"Bateman","year":"2021","journal-title":"Paediatr Perinat Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2018.01.008","article-title":"Course-, dose-, and stage-dependent toxic effects of prenatal dexamethasone exposure on fetal articular cartilage development","volume":"286","author":"Chen","year":"2018","journal-title":"Toxicol Lett"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.taap.2018.05.005","article-title":"Course-, dose-, and stage-dependent toxic effects of prenatal dexamethasone exposure on long bone development in fetal mice","volume":"351","author":"Chen","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"9603271211072870","DOI":"10.1177\/09603271211072870","article-title":"Antenatal dexamethasone retarded fetal long bones growth and development by Down-regulating of insulin-like growth factor 1 signaling in fetal rats","volume":"41","author":"Qiu","year":"2022","journal-title":"Hum Exp Toxicol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0012-1606(60)90011-7","article-title":"The effect of tetracycline on the development of the skeletal system of the Chick embryo","volume":"2","author":"Bevelander","year":"1960","journal-title":"Dev Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e22613","DOI":"10.1002\/jbt.22613","article-title":"Influence of doxycycline administration on rat embryonic development during organogenesis","volume":"35","author":"Abd-Allah","year":"2021","journal-title":"J Biochem Mol Toxicol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1111\/bcp.13364","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study","volume":"83","author":"Muanda","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/bdd.2272","article-title":"When special populations intersect with drug-drug interactions: application of physiologically-based pharmacokinetic modeling in pregnant populations","volume":"42","author":"Sychterz","year":"2021","journal-title":"Biopharm Drug Dispos"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/psp4.12274","article-title":"Drug dosing in pregnant women: challenges and opportunities in using physiologically based pharmacokinetic modeling and simulations","volume":"7","author":"Ke","year":"2018","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"year":"2013","key":"ref38"},{"key":"ref39","first-page":"453","article-title":"A Meta-analysis of pregnant women after extended use magnesium sulfate neonatal appear abnormal changes of bone (in Chinese)","volume":"31","author":"Gao","year":"2015","journal-title":"J Practical Obstet Gynecol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/sj.jp.7211508","article-title":"Skeletal demineralization and fractures caused by fetal magnesium toxicity","volume":"26","author":"Wedig","year":"2006","journal-title":"J Perinatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.3390\/nu12123786","article-title":"Metabolic bone disease of prematurity: risk factors and associated short-term outcomes","volume":"12","author":"Avila-Alvarez","year":"2020","journal-title":"Nutrients"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"10666","DOI":"10.3390\/ijms231810666","article-title":"Don't forget the bones: incidence and risk factors of metabolic bone disease in a cohort of preterm infants","volume":"23","author":"Perrone","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1038\/s41372-021-01065-y","article-title":"Evaluation of radiologic evidence of metabolic bone disease in very low birth weight infants at fourth week of life","volume":"41","author":"Kavurt","year":"2021","journal-title":"J Perinatol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1377070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:30:08Z","timestamp":1727670608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1377070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":43,"alternative-id":["10.3389\/fpubh.2024.1377070"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1377070","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"article-number":"1377070"}}